US ex rel. Constance Conrad v. Forest Pharmaceuticals, Inc.
Bailey Glasser secured a $24.5 million settlement in the civil portion of qui tam claims that Forest sold unapproved thyroid drug.
Bailey Glasser secured a $24.5 million settlement in the civil portion of qui tam claims that Forest sold unapproved thyroid drug.
Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you are agreeing to our Cookie Policy.